Softwr

Healthcare · head to head

NextGen Enterprise EHR vs Therapixel

NextGen Enterprise EHR logo

NextGen Enterprise EHR

Healthcare

Enterprise-grade EHR and RCM for large healthcare organizations

From
On request
Rated
-
Full reviewWebsite
Therapixel logo

Therapixel

Healthcare

French mammography AI with FDA clearances for 2D and tomosynthesis breast screening

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: NextGen Enterprise EHR no pricing published on website; Therapixel european and American regulatory positions were established under different regimes, and under the EU Medical Device Regulation this class of diagnostic AI faces a higher classification and notified body scrutiny, so European buyers must verify the current MDR certificate and expiry rather than relying on a legacy CE reference.
  • They diverge on capability: NextGen Enterprise EHR covers Electronic Health Records, Therapixel covers MammoScreen 2D.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which NextGen Enterprise EHR and Therapixel actually diverge.

Attributes where NextGen Enterprise EHR and Therapixel differ
AttributeNextGen Enterprise EHRTherapixel
PlatformsWeb, DesktopWeb
Founded1997Unknown

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in NextGen Enterprise EHR

  • Electronic Health Records
  • Clinical Documentation
  • Revenue Cycle Management
  • Patient Management
  • Analytics
  • Interoperability
  • Reporting
  • HL7

Only in Therapixel

  • MammoScreen 2D
  • MammoScreen DBT
  • One to ten suspicion score
  • Summary report
  • Workstation and PACS delivery
  • Reading workflow configurations

What people use each for

The jobs each tool is most often brought in to do.

NextGen Enterprise EHR

  • Patient Carenot Therapixel
  • Medical Recordsnot Therapixel
  • Practice Managementnot Therapixel
  • Telehealthnot Therapixel

Therapixel

  • A European breast screening programme running mandatory double reading that wants to evaluate AI as a concurrent or second reader within what national guidance permitsnot NextGen Enterprise EHR
  • An American breast centre that has moved to tomosynthesis and needs reading support on DBT specifically, which Therapixel holds a clearance fornot NextGen Enterprise EHR
  • A screening service wanting a graded suspicion score rather than a binary flag so readers can calibrate their own thresholdnot NextGen Enterprise EHR
  • A radiology group evaluating multiple mammography AI vendors head to head on their own historic case set before committingnot NextGen Enterprise EHR

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

NextGen Enterprise EHR

  • No pricing published on website

Therapixel

  • European and American regulatory positions were established under different regimes, and under the EU Medical Device Regulation this class of diagnostic AI faces a higher classification and notified body scrutiny, so European buyers must verify the current MDR certificate and expiry rather than relying on a legacy CE reference.
  • MammoScreen does mammography only, so a hospital wanting AI across head CT, chest and breast needs several vendors and several PACS integrations, or an orchestration layer bought from someone else.
  • Therapixel is a small French company competing against Hologic and iCAD, which have incumbency inside the mammography reading workstation, so integration into an American breast centre is more work than it is for the workstation vendor own AI.
  • Detection performance is sensitive to the mammography unit vendor and acquisition protocol, so published results do not transfer between estates and each site needs local validation it must fund itself.
  • Whether AI can substitute for one of two human readers is a national workforce and liability question, not a product capability, so the labour saving that justifies the purchase in one country is not permitted in another.

Pricing, plan by plan

NextGen Enterprise EHR

On request

No published plan breakdown. See the NextGen Enterprise EHR review.

Therapixel

On request
  • MammoScreen$undefined/year
    • Priced per examination or by annual screening volume
    • 2D and tomosynthesis licensed by the versions cleared for each
    • Cloud or on premises deployment quoted differently

Which should you pick?

Choose NextGen Enterprise EHR if

  • You need electronic health records.
  • You work on Web, Desktop.
  • You also want clinical documentation.
NextGen Enterprise EHR review

Choose Therapixel if

  • You need mammoscreen 2d.
  • You also want mammoscreen dbt.
Therapixel review

Questions people ask

Is NextGen Enterprise EHR or Therapixel better?
Neither clearly leads. NextGen Enterprise EHR starts at On request and Therapixel at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, NextGen Enterprise EHR or Therapixel?
NextGen Enterprise EHR starts at On request and Therapixel at On request.
Does NextGen Enterprise EHR or Therapixel run on more platforms?
NextGen Enterprise EHR runs on Web, Desktop. Therapixel runs on Web.
What is NextGen Enterprise EHR best used for?
NextGen Enterprise EHR is most often used for patient care, medical records, practice management, telehealth. Of those, patient care and medical records are not what Therapixel is typically brought in for.
What can NextGen Enterprise EHR do that Therapixel cannot?
NextGen Enterprise EHR covers Electronic Health Records, Clinical Documentation, Revenue Cycle Management, Patient Management. Therapixel covers MammoScreen 2D, MammoScreen DBT, One to ten suspicion score, Summary report.

Answered from the vendors’ own pages

NextGen Enterprise EHR: What is NextGen Enterprise EHR pricing?

NextGen Healthcare does not publish pricing for its Enterprise solutions on their website. The company uses a consultative sales model where pricing is determined after understanding specific practice requirements and needed features.

Source
Therapixel: Is MammoScreen FDA cleared?

Yes. It holds 510(k) clearance K192854 for two dimensional mammography from July 2020, a November 2021 clearance for digital breast tomosynthesis, and two further clearances in October 2024 for later versions.

Therapixel: Is it CE marked?

Yes, but European buyers should ask specifically for the current certificate under the Medical Device Regulation and its expiry date, because this class of diagnostic AI moved to a higher classification under MDR.

Therapixel: What does the one to ten score mean?

It is a graded suspicion score per finding and per study, designed to be integrated alongside a radiologist BI-RADS assessment rather than treated as a positive or negative result.

Therapixel: Does it cover anything besides mammography?

No. It is a mammography product only, including tomosynthesis. Other body regions need a different vendor.

Share

Related pages

More on NextGen Enterprise EHR

More on Therapixel

Keep looking

Other head to heads